Conditional overexpression of liver receptor homolog-1 in female mouse mammary epithelium results in altered mammary morphogenesis via the induction of tgf-ß

Endocrinology

Volumn 155, Issue 5, 2014, Pages 1606-1617

  Lazarus, Kyren A ^a,b   Brown, Kristy A ^a   Young, Morag J ^a   Zhao, Zhe ^a   Coulson, Rhiannon S ^a   Chand, Ashwini L ^a   Clyne, Colin D ^a,c  

^a HUDSON INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b SWINBURNE UNIVERSITY OF TECHNOLOGY   (Australia)

^c MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

LIVER RECEPTOR HOMOLOG 1; SMAD2 PROTEIN; SMAD3 PROTEIN; SMALL INTERFERING RNA; TRANSFORMING GROWTH FACTOR BETA;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST DEVELOPMENT; BREAST EPITHELIUM; CELL STRAIN MCF 7; CONTROLLED STUDY; FEMALE; GENE SILENCING; IN VITRO STUDY; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE;

ANIMALS; BREAST NEOPLASMS; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HUMANS; MAMMARY GLANDS, ANIMAL; MCF-7 CELLS; MICE; MICE, TRANSGENIC; MORPHOGENESIS; NEOPLASM PROTEINS; PROTEIN ISOFORMS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; SMAD PROTEINS, RECEPTOR-REGULATED; TRANSFORMING GROWTH FACTOR BETA; UP-REGULATION;

EID: 84899465776     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2013-1948     Document Type: Article

References (46)

1. Lazarus KA, Wijayakumara D, Chand AL, Simpson ER, Clyne CD. Therapeutic potential of liver receptor homolog-1 modulators. J Steroid Biochem Mol Biol. 2012;130:138-146
2. Duggavathi R, Volle DH, Mataki C, et al. Liver receptor homolog 1 is essential for ovulation. Genes Dev. 2008;22:1871-1876 (Pubitemid 352008636)
3. Zhang C, Large MJ, Duggavathi R, et al. Liver receptor homolog-1 is essential for pregnancy. Nat Med. 2013;19:1061-1066
4. Benod C, Vinogradova MV, Jouravel N, Kim GE, Fletterick RJ, Sablin EP. Nuclear receptor liver receptor homologue 1 (LRH-1) regulates pancreatic cancer cell growth and proliferation. Proc Natl Acad Sci USA. 2011;108:16927-16931
5. Schoonjans K, Dubuquoy L, Mebis J, et al. Liver receptor homolog 1 contributes to intestinal tumor formation through effects on cell cycle and inflammation. Proc Natl Acad Sci USA. 2005;102:2058- 2062 (Pubitemid 40262011)
6. Wang SL, Zheng DZ, Lan FH, et al. Increased expression of hLRH-1 in human gastric cancer and its implication in tumorigenesis. Mol Cell Biochem. 2008;308:93-100
7. Miki Y, Clyne CD, Suzuki T, et al. Immunolocalization of liver receptor homologue-1 (LRH-1) in human breast carcinoma: possible regulator of in situ steroidogenesis. Cancer Lett. 2006;244:24- 33 (Pubitemid 44485861)
8. Saxena D, Escamilla-Hernandez R, Little-Ihrig L, Zeleznik AJ. Liver receptor homolog-1 and steroidogenic factor-1 have similar actions on rat granulosa cell steroidogenesis. Endocrinology. 2007;148: 726-734 (Pubitemid 46150778)
9. Clyne CD, Speed CJ, Zhou J, Simpson ER. Liver receptor homologue- 1 (LRH-1) regulates expression of aromatase in preadipocytes. J Biol Chem. 2002;277:20591-20597 (Pubitemid 34967360)
10. Annicotte JS, Chavey C, Servant N, et al. The nuclear receptor liver receptor homolog-1 is an estrogen receptor target gene. Oncogene. 2005;24:8167-8175 (Pubitemid 41759815)
11. Thiruchelvam PT, Lai CF, Hua H, et al. The liver receptor homolog- 1 regulates estrogen receptor expression in breast cancer cells. Breast Cancer Res Treat. 2011;127:385-396
12. Chand AL, Wijayakumara DD, Knower KC, et al. The orphan nuclear receptor LRH-1 andERα activateGREB1expression to induce breast cancer cell proliferation. PLoS One. 2012;7:e31593
13. Chand AL, Herridge KA, Thompson EW, Clyne CD. The orphan nuclear receptor LRH-1 promotes breast cancer motility and invasion. Endocr Relat Cancer. 2010;17:965-975
14. Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative CT method. Nat Protoc. 2008;3:1101-1108
15. Du P, Kibbe WA, Lin SM. lumi: A pipeline for processing Illumina microarray. Bioinformatics. 2008;24:1547-1548
16. Lin SM, Du P, Huber W, Kibbe WA. Model-based variance-stabilizing transformation for Illumina microarray data. Nucleic Acids Res. 2008;36:e11
17. Gunther EJ, Belka GK, Wertheim GB, Wang J, Hartman JL, Boxer RB, Chodosh LA. A novel doxycycline-inducible system for the transgenic analysis of mammary gland biology. FASEB J. 2002;16: 283-292 (Pubitemid 34195290)
18. Radisky ES, Radisky DC. Matrix metalloproteinase-induced epithelial- mesenchymal transition in breast cancer. J Mammary Gland Biol Neoplasia. 2010;15:201-212
19. Lee HW, Park YM, Lee SJ, et al. Alpha-smooth muscle actin (ACTA2) is required for metastatic potential of human lung adenocarcinoma. Clin Cancer Res. 2013;19:5879-5889
20. Zeng X, Zhang S, Xu L, Yang H, He S. Activation of proteaseactivated receptor 2-mediated signaling by mast cell tryptase modulates cytokine production in primary cultured astrocytes. Mediators Inflamm. 2013;2013:10
21. Rhee DK, Park SH, Jang YK. Molecular signatures associated with transformation and progression to breast cancer in the isogenic MCF10 model. Genomics. 2008;92:419-428
22. Zhang L, Lim SL, Du H, et al. High temperature requirement factor A1 (HTRA1) gene regulates angiogenesis through transforming growth factor-ß family member growth differentiation factor 6. J Biol Chem. 2012;287:1520-1526
23. Chen SJ, Yuan W, Mori Y, et al. Stimulation of type I collagen transcription in human skin fibroblasts by TGF-[beta]: Involvement of Smad 3. J Invest Dermatol. 1999;112:49-57 (Pubitemid 29024705)
24. Ingman WV, Robertson SA. Mammary gland development in transforming growth factor ß1 null mutant mice: Systemic and epithelial effects. Biol Reprod. 2008;79:711-717
25. Silberstein GB, DanielCW.Reversible inhibition ofmammarygland growth by transforming growth factor-ß. Science. 1987;237:291- 293 (Pubitemid 17095150)
26. BotrugnoOA,Fayard E, Annicotte JS, et al. Synergy betweenLRH-1 and ß-catenin induces G1 cyclin-mediated cell proliferation. Mol Cell. 2004;15:499-509 (Pubitemid 39141778)
27. Chand AL, Herridge KA, Thompson EW, Clyne CD. 2010 The orphan nuclear receptorLRH-1promotes breast cancer motility and invasion. Endocr Relat Cancer. 2010;17:965-975
28. Annes JP, Chen Y, Munger JS, Rifkin DB. Integrin αVß6- mediated activation of latent TGF-ß requires the latent TGF-ß binding protein- 1. J Cell Biol. 2004;165:723-734
29. de Graauw M, van MiltenburgMH,Schmidt MK, et al. Annexin A1 regulates TGF-ß signaling and promotes metastasis formation of basal-like breast cancer cells. Proc Natl Acad Sci USA. 2010;107: 6340-6345
30. Cordenonsi M, Dupont S, Maretto S, Insinga A, Imbriano C, Piccolo S. Links between tumor suppressors: p53 is required for TGF-ß gene responses by cooperating with Smads. Cell. 2003; 113:301-314 (Pubitemid 36556113)
31. Uttamsingh S, Bao X, Nguyen KT, et al. Synergistic effect between EGF and TGF-ß1 in inducing oncogenic properties of intestinal epithelial cells. Oncogene. 2008;27:2626-2634 (Pubitemid 351550880)
32. Fanayan S, Firth SM, Butt AJ, Baxter RC. Growth inhibition by insulin-like growth factor-binding protein-3 in T47D breast cancer cells requires transforming growth factor-ß (TGF-ß) and the type II TGF-ß receptor. J Biol Chem. 2000;275:39146-39151 (Pubitemid 32058930)
33. Silberstein GB, Flanders KC, Roberts AB, DanielCW.Regulation of mammary morphogenesis: Evidence for extracellular matrix-mediated inhibition of ductal budding by transforming growth factor-ß1. Dev Biol. 1992;152:354-362
34. Robinson SD, Silberstein GB, Roberts AB, Flanders KC, DanielCW. Regulated expression and growth inhibitory effects of transforming growth factor-ß isoforms in mouse mammary gland development. Development. 1991;113:867-878 (Pubitemid 21900326)
35. Daniel CW, Silberstein GB, Van Horn K, Strickland P, Robinson S. TGF-ß1-induced inhibition of mouse mammary ductal growth: Developmental specificity and characterization. Dev Biol. 1989;135: 20-30 (Pubitemid 19225281)
36. Silberstein GB. Postnatal mammary gland morphogenesis. Microsc Res Tech. 2001;52:155-162 (Pubitemid 32107803)
37. Silberstein GB, Strickland P, Coleman S, Daniel CW. Epitheliumdependent extracellular matrix synthesis in transforming growth factor-ß 1-growth-inhibited mouse mammary gland. J Cell Biol. 1990;110:2209-2219
38. Daniel CW, Robinson S, Silberstein GB. The role of TGF-ß in patterning and growth of the mammary ductal tree. J Mammary Gland Biol Neoplasia. 1996;1:331-341
39. Daniel CW, Robinson SD. Regulation of mammary growth and function by TGF-ß. Mol Reprod Dev. 1992;32:145-151
40. Fayard E, Auwerx J, Schoonjans K. LRH-1: An orphan nuclear receptor involved in development, metabolism and steroidogenesis. Trends Cell Biol. 2004;14:250-260 (Pubitemid 38591329)
41. Lai CF, Flach KD, Alexi X, et al. 2013 Co-regulated gene expression by oestrogen receptor α and liver receptor homolog-1 is a feature of the oestrogen response in breast cancer cells. Nucleic Acids Res. 2013;41:10228-10240
42. Kim SJ, Angel P, Lafyatis R, et al. Autoinduction of transforming growth factor α 1 is mediated by the AP-1 complex. Mol Cell Biol. 1990;10:1492-1497
43. Massagué J. TGFß in cancer. Cell. 2008;134:215-230
44. Polyak K, Weinberg R. Transitions between epithelial and mesenchymal states: Acquisition of malignant and stem cell traits. Nat Rev Cancer. 2009;9:265-273
45. Zavadil J, Cermak L, Soto-Nieves N, Böttinger EP. 2004 Integration of TGF-[beta]/Smad and Jagged1/Notch signalling in epithelial-tomesenchymal transition. EMBO J. 2004;23:1155-1165
46. Guo X, Wang XF. Signaling cross-talk between TGF-ß/BMP and other pathways. Cell Res. 2009;19:71-88